Cargando…

Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA

BACKGROUND: Merkel cell carcinoma (MCC) is a rare and aggressive type of cancer with poor outcomes. OBJECTIVE: To describe treatment patterns, overall survival, and healthcare costs associated with advanced MCC (aMCC) using data from Medicare enrollees who received an aMCC diagnosis in the USA State...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steuten, Lotte, Garmo, Vincent, Phatak, Hemant, Sullivan, Sean D., Nghiem, Paul, Ramsey, Scott D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748883/ https://www.ncbi.nlm.nih.gov/pubmed/31250217 http://dx.doi.org/10.1007/s40258-019-00492-5

Ejemplares similares

Travel burden associated with rare cancers: The example of Merkel cell carcinoma
por: Jain, Rahul, et al.
Publicado: (2019)

Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
por: Lanitis, Tereza, et al.
Publicado: (2019)

Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma
por: Nghiem, Paul, et al.
Publicado: (2017)

Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy
por: Zheng, Ying, et al.
Publicado: (2021)

Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
por: D'Angelo, S.P., et al.
Publicado: (2021)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
por: D’Angelo, Sandra P., et al.
Publicado: (2019)

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
por: Bharmal, Murtuza, et al.
Publicado: (2019)

Nomogram prediction for the overall survival and cancer-specific survival of patients diagnosed with Merkel cell carcinoma
por: Yin, Xufeng, et al.
Publicado: (2021)

Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma
por: von der Grün, Jens, et al.
Publicado: (2019)

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
por: Carter, Joseph J., et al.
Publicado: (2009)

Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
por: Bhatia, Shailender, et al.
Publicado: (2022)

The Association of Radiation Therapy and Chemotherapy on Overall Survival in Merkel Cell Carcinoma: A Population-Based Analysis
por: Vayntraub, Aleksander, et al.
Publicado: (2021)

Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs
por: Haslem, Derrick S., et al.
Publicado: (2018)

P29. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors
por: Lyngaa, L, et al.
Publicado: (2014)

Insights into anti-tumor immunity via the polyomavirus shared across human Merkel cell carcinomas
por: Jani, Saumya, et al.
Publicado: (2023)

Does a new polyomavirus contribute to Merkel cell carcinoma?
por: Garneski, Kelly M, et al.
Publicado: (2008)

Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma—A Retrospective Analysis of A Swedish Cohort
por: Björn Andtback, Hannah, et al.
Publicado: (2021)

Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally
por: Esposito, Andrew, et al.
Publicado: (2021)

Histopathologic Features for Overall Survival in Merkel Cell Carcinoma: A Case Series with Intact Mismatch Repair Protein Expression
por: Kestel, Selin, et al.
Publicado: (2023)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
por: Foulongne, Vincent, et al.
Publicado: (2008)

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
por: Miller, Natalie J., et al.
Publicado: (2018)

A web-based predictive model for overall survival of patients with cutaneous Merkel cell carcinoma: A population-based study
por: Xu, Wen, et al.
Publicado: (2022)

Systemic immune suppression as a stage-independent predictor of diminished Merkel cell carcinoma-specific survival
por: Paulson, Kelly G., et al.
Publicado: (2012)

Evaluation of disease management programmes for chronically ill
por: Steuten, Lotte
Publicado: (2006)

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
por: Bullement, Ash, et al.
Publicado: (2019)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy
por: Peters, Max, et al.
Publicado: (2016)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma
por: Pietropaolo, Valeria, et al.
Publicado: (2020)

DETECTing Merkel Cell Polyomavirus in Merkel Tumors
por: Arora, Reety, et al.
Publicado: (2020)

How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model
por: Church, Candice, et al.
Publicado: (2015)

Complete Spontaneous Regression of Merkel Cell Carcinoma Metastatic to the Liver: Did Lifestyle Modifications and Dietary Supplements Play a Role?
por: Vandeven, Natalie, et al.
Publicado: (2012)

Survival of Patients With Head and Neck Merkel Cell Cancer: Findings From the Pan-Canadian Merkel Cell Cancer Collaborative
por: Nayak, Ameeta Lubina, et al.
Publicado: (2023)

The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
por: Harms, Paul W., et al.
Publicado: (2018)

Trends in overall survival and costs of multiple myeloma, 2000–2014
por: Fonseca, R, et al.
Publicado: (2017)

Healthcare utilisation and cost expenditures for pneumonia in individuals with diabetes mellitus in the USA
por: Liu, K., et al.
Publicado: (2019)

Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study
por: de Ligt, Kelly M., et al.
Publicado: (2018)

Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival
por: Verhaegen, Monique E., et al.
Publicado: (2014)

Merkel cell polyomavirus and cutaneous Merkel cell carcinoma
por: Minutilli, Ettore, et al.
Publicado: (2016)

Merkel cell polyomavirus and associated Merkel cell carcinoma
por: Yang, June F., et al.
Publicado: (2021)

Predicting Hospital Overall Quality Star Ratings in the USA
por: Kurian, Nisha, et al.
Publicado: (2021)

How we treat Merkel cell carcinoma: within and beyond current guidelines
por: Park, Song Y, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbrucfp19qkk0otfs1jmslb74l